RG
Publications
229
Views
92,572
Downloads
6,149
Supervised works
19
Items per page
1 - 229 of 229
Title Published in Access level OA Policy Year Views Downloads
Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in RatsMolecular Pharmaceutics
accessLevelRestricted
2020 313 2
Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimodEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2019 330 2
Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone DeliveryOtology & Neurotology
accessLevelRestricted
2019 394 0
Effect of implantation site on outcome of tissue-engineered vascular graftsEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2019 433 1
A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapyInternational journal of pharmaceutics
accessLevelRestricted
2015 901 2
Controlled drug release from melt-extrudates through processing parameters: A chemometric approachInternational journal of pharmaceutics
accessLevelRestricted
2015 652 0
Strategies for formulating and delivering poorly water-soluble drugsJournal of drug delivery science and technology
accessLevelRestricted
2015 839 1
New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular toleranceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2015 683 1
Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applicationsJournal of chromatography
accessLevelRestricted
2013 657 5
Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2013 682 2
In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular applicationJournal of controlled release
accessLevelRestricted
2013 624 0
In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymerJournal of controlled release
accessLevelRestricted
2013 667 1
In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye diseaseEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2012 706 0
Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivativesCarbohydrate Polymers
accessLevelRestricted
2012 451 0
Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement modelBiomaterials
accessLevelRestricted
2012 772 0
Advantages of bilayered vascular grafts for surgical applicability and tissue regenerationActa biomaterialia
accessLevelRestricted
2012 710 0
Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defectJournal of biomedical materials research. Part A
accessLevelRestricted
2011 731 0
Novel micelle formulations to increase cutaneous bioavailability of azole antifungalsJournal of controlled release
accessLevelRestricted
2011 637 3
The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formationJournal of controlled release
accessLevelRestricted
2010 643 0
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in miceJournal of controlled release
accessLevelRestricted
2010 747 3
Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicityInternational Journal of Pharmaceutics
accessLevelRestricted
2010 419 1
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2)International journal of pharmaceutics
accessLevelRestricted
2010 677 0
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation?Circulation
accessLevelRestricted
2009 648 1
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eyeInvestigative ophthalmology & visual science
accessLevelRestricted
2009 595 0
Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritisJournal of controlled release
accessLevelPrivate
2009 715 0
Novel thermosensitive chitosan hydrogels: in vivo evaluationJournal of biomedical materials research. Part A
accessLevelRestricted
2009 691 3
Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancerJournal of Drug Targeting
accessLevelRestricted
2009 443 0
Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systemsJournal of controlled release
accessLevelRestricted
2009 634 0
A high throughput protein formulation platform: case study of salmon calcitoninPharmaceutical research
accessLevelPublic
2009 649 574
Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)-micro- and nanofiber-based small diameter vascular graftsJournal of biomedical materials research. Part A
accessLevelPrivate
2009 583 0
Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastasesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2009 671 0
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle sizeEuropean journal of pharmaceutical sciences
accessLevelRestricted
2009 656 0
Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective modelNanomedicine
accessLevelPrivate
2009 649 0
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activityJournal of Drug Targeting
accessLevelRestricted
2009 408 1
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cellsEuropean journal of pharmaceutical sciences
accessLevelRestricted
2009 603 0
A novel thermoresponsive hydrogel based on chitosanEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 742 1
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compoundDrug development and industrial pharmacy
2008 606 0
High throughput methods to characterize protein permeation and releaseInternational journal of pharmaceutics
accessLevelRestricted
2008 837 3
Colloidal Drug Delivery Systems - Recent Advances With Polymeric MicellesChimia
accessLevelRestricted
2008 930 38
Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cellsEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelRestricted
2008 514 1
In vivo photodynamic activity of photosensitizer-loaded nanoparticles : formulation properties, administration parameters and biological issues involved in PDT outcomeEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 686 1
A biodegradable drug delivery system for the treatment of postoperative inflammationInternational journal of pharmaceutics
accessLevelRestricted
2008 515 1
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucomaInvestigative ophthalmology & visual science
accessLevelRestricted
2008 686 0
Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic acid and 5-aminolevulinic acid derivativesAntimicrobial agents and chemotherapy
accessLevelRestricted
2008 753 0
Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervixJournal of pharmaceutical sciences
accessLevelRestricted
2008 649 0
Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA : PEO Diblock and Triblock CopolymersJournal of drug targeting
accessLevelRestricted
2008 43 0
Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulationCirculation
accessLevelRestricted
2008 635 0
Nanoparticles for drug delivery : the need for precision in reporting particle size parametersEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2008 677 2
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticlesInternational journal of pharmaceutics
accessLevelRestricted
2007 655 0
Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugationInternational journal of pharmaceutics
accessLevelRestricted
2007 699 7
Biological conversion of a water-soluble prodrug of cyclosporine AEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2007 641 8
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymesBioconjugate chemistry
accessLevelRestricted
2007 648 0
Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systemsJournal of biomedical materials research. Part A
accessLevelRestricted
2007 671 2
Polymeric photosensitizer prodrugs for photodynamic therapyPhotochemistry and photobiology
accessLevelPrivate
2007 657 0
NIR analysis of cellulose and lactose—Application to ecstasy tablet analysisForensic science international
accessLevelRestricted
2007 937 1
The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systemsAdvanced drug delivery reviews
accessLevelRestricted
2007 668 2
Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degenerationInvestigative ophthalmology & visual science
accessLevelRestricted
2007 539 0
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagusJournal of controlled release
accessLevelPrivate
2007 678 0
Characterization of protein aggregation: the case of a therapeutic immunoglobulinBiochimica et biophysica acta
accessLevelRestricted
2007 639 0
Detection and characterization of protein aggregates by fluorescence microscopyInternational journal of pharmaceutics
accessLevelRestricted
2007 642 0
High throughput screening of protein formulation stability: practical considerationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2007 646 0
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in ratsMolecular vision
accessLevelPublic
2006 76 66
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coatingAAPS PharmSciTech
accessLevelPublic
2006 580 197
Biodegradable nanoparticles for direct or two-step tumor immunotargetingBioconjugate chemistry
accessLevelRestricted
2006 506 0
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structuresBiomaterials
accessLevelRestricted
2006 511 1
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancerInternational journal of pharmaceutics
accessLevelRestricted
2006 552 1
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides)International journal of pharmaceutics
accessLevelRestricted
2006 568 4
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: An EPR imaging studyJournal of controlled release
accessLevelRestricted
2006 180 0
An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical AdministrationDrugs in R&D
accessLevelPublic
2006 123 103
Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pHInternational journal of pharmaceutics
accessLevelRestricted
2006 530 1
Intraocular implants for extended drug delivery: therapeutic applicationsAdvanced drug delivery reviews
accessLevelRestricted
2006 629 1
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregatesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2006 380 1
Biodegradable scleral implants as new triamcinolone acetonide delivery systemsInternational journal of pharmaceutics
accessLevelRestricted
2006 487 1
5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and PerspectivesPhotochemistry and photobiology
accessLevelRestricted
2006 86 0
In vitro and in vivo activities of verteporfin-loaded nanoparticlesJournal of Controlled Release
accessLevelRestricted
2005 179 0
Coupling Methods to Obtain Ligand-Targeted Liposomes and NanoparticlesMicroencapsulation : methods and industrial applications
accessLevelRestricted
2005 65 0
Conversion of cyclosporine A prodrugs in human tears vs rabbits tearsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2005 464 0
Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the EyeChimia
accessLevelRestricted
2005 457 0
A water-soluble prodrug of cyclosporine A for ocular application: A stability studyEuropean journal of pharmaceutical sciences
accessLevelPublic
2005 822 661
Trans-scleral diffusion of triamcinolone acetonideCurrent eye research
accessLevelRestricted
2005 541 1
The use of drug-loaded nanoparticles in cancer chemotherapyMicroencapsulation : Methods and Industrial Applications
accessLevelRestricted
2005 57 0
Pseudo-thermosetting chitosan hydrogels for biomedical applicationInternational journal of pharmaceutics
accessLevelRestricted
2005 544 1
Ecole de Pharmacie Geneve-Lausanne: A novel center of excellence in GenevaChimia
2005 386 0
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kineticsInternational journal of pharmaceutics
accessLevelRestricted
2005 537 1
Synthesis and Ring-Opening Polymerization of New Monoalkyl-Substituted LactidesJournal of polymer science. Part A, Polymer chemistry
accessLevelRestricted
2004 248 0
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryosInternational journal of pharmaceutics
accessLevelRestricted
2004 515 1
Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performanceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 549 0
New surface-active polymers for ophthalmic formulations: evaluation of ocular toleranceEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 494 3
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 577 1
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targetingEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 443 4
Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2004 526 1
Current Methods for Attaching Targeting Ligands to Liposomes and NanoparticlesJournal of Pharmaceutical Sciences
accessLevelRestricted
2004 167 0
Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradationJournal of biomedical materials research. Part A
accessLevelRestricted
2003 186 0
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticlesInvestigative Ophthalmology & Visual Science
accessLevelPublic
2003 472 159
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapyEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2003 646 0
Bioadhesive Ophthalmic Drug Inserts (BODI)Modified-release drug delivery technology
accessLevelPublic
2003 95 121
In Vitro Monitoring of Poly(ortho ester) Degradation by Electron Paramagnetic Resonance ImagingMacromolecules
accessLevelRestricted
2003 764 0
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologiesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2003 472 1
Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic ActivityPhotochemistry and photobiology
accessLevelRestricted
2003 69 0
Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humansAAPS PharmSci
accessLevelRestricted
2002 569 0
Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine deliveryJournal of controlled release
accessLevelRestricted
2002 514 0
Ocular tolerance of absorption enhancers in ophthalmic preparationsAAPS PharmSci
accessLevelRestricted
2002 451 1
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticlesInternational journal of pharmaceutics
accessLevelRestricted
2002 464 2
State of the art in the delivery of photosensitizers for photodynamic therapyJournal of photochemistry and photobiology. B, Biology
accessLevelRestricted
2002 67 0
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eyeInvestigative ophthalmology and visual science
accessLevelPublic
2002 195 107
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicleAAPS PharmSci
accessLevelRestricted
2001 499 0
Therapeutic applications of viscous and injectable poly(ortho esters)Advanced drug delivery reviews
accessLevelRestricted
2001 511 1
Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded NanoparticlesPharmaceutical research
accessLevelPublic
2001 54 103
Fluorescence correlation spectroscopy for the characterisation of drug delivery systemsBiological chemistry
accessLevelRestricted
2001 491 0
Challenges of Intraocular Drug DeliveryEuropean pharmaceutical review
accessLevelPublic
2001 106 12
Influence of hot-melt extrusion and compression molding on polymer structure organization, investigated by differential scanning calorimetryJournal of Applied Polymer Science
accessLevelRestricted
2001 355 0
Release of BSA from poly(ortho ester) extruded thin strandsJournal of Controlled Release
accessLevelRestricted
2001 258 0
A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgeryInvestigative Ophthalmology & Visual Science
accessLevelPublic
2001 308 107
Treatment of Intralocular Diseases with Poly(ortho ester)-Based Drug Delivery SystemsMacromolecular symposia
accessLevelRestricted
2001 110 0
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogsAAPS PharmSci
accessLevelRestricted
2001 540 0
Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulationInternational journal of pharmaceutics
accessLevelRestricted
2001 470 1
Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocketBiomaterials
accessLevelRestricted
2001 468 1
Protein Release from Poly(ortho ester) Extruded RodsMacromolecular symposia
accessLevelRestricted
2001 80 0
Development of poly(ortho esters)Drug delivery systems & sciences
accessLevelRestricted
2001 405 1
Polymeric systems for ophthalmic drug deliveryPolymeric Biomaterials
accessLevelRestricted
2001 59 0
Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particlesInternational journal of pharmaceutics
accessLevelRestricted
2001 538 1
Poly(ortho esters) - A Versatile Drug Delivery SystemBiomaterials and Drug Delivery toward New Mellenium
accessLevelRestricted
2000 426 0
Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle TechnologyPharmaceutical research
accessLevelPublic
2000 66 130
Poly (ortho esters) implants for the sustained delivery of a protein factors influencing the release behaviour of BSA in vitroThe 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference
accessLevelPublic
2000 51 54
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateJournal of controlled release
accessLevelRestricted
2000 191 0
Poly(ortho esters) - their development and some recent applicationsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 539 1
Local delivery of antimicrobial agents for the treatment of periodontal diseasesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 433 1
Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradationBiomaterials
accessLevelRestricted
2000 548 2
A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro releaseEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 661 0
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactantsInternational journal of pharmaceutics
accessLevelRestricted
2000 451 1
A novel analytical approach for the characterization of poly(MePegcyanoacrylate - co - hexadecylcyanoacrylate) nanoparticlesThe 27th International Symposium on Controlled Release of Bioactive Materials and the Third Consumer and Diversified Products Conference
accessLevelPublic
2000 50 32
Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer NanoparticlesPharmaceutical development and technology
accessLevelRestricted
2000 66 0
Chitosan as Tear Substitute: A Wetting Agent Endowed with Antimicrobial EfficacyJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
2000 121 0
Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinsesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 491 1
Formation of peptide impurities in polyester matrices during implant manufacturingEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
2000 601 0
Formulation and technology aspects of conrolled drug delivery in animalsPharmaceutical science & technology today
accessLevelRestricted
2000 78 0
Design and development of controlled release veterinary drug delivery systems to the eyeControlled Release Veterinary Drug Delivery
accessLevelRestricted
2000 138 0
Freeze-drying of PLA-PEO nanoparticles : from basic principles to rational optimizationCRS proceedings
accessLevelPublic
1999 227 29
Production of biodegradable implants for the sustained release of pharmaceuticalsAsian Conference and Exhibition of Controlled Release
accessLevelRestricted
1999 422 1
Evaluation of the local and systemic inflammatory responses induced by the subcutaneous injection of different biopolymersCRS proceedings
accessLevelPublic
1999 49 30
Cellular uptake of nanoparticles made of poly(lactic acid), poly(ethylene oxide) diblock and triblock copolymersCRS proceedings
accessLevelPublic
1999 52 24
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retentionInternational journal of pharmaceutics
accessLevelRestricted
1999 523 1
Hydrolysis and Erosion Studies of Autocatalyzed Poly(ortho esters) Containing Lactoyl−Lactyl Acid DimersMacromolecules
accessLevelRestricted
1999 157 0
How to avoid the formation of peptide impurities during manufacturing of implants by melt-extrusion ?CRS proceedings
accessLevelPublic
1999 50 32
A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular applicationJournal of biomedical materials research
accessLevelPublic
1999 166 171
Erosion, properties and drug release from a new family of poly(ortho esters)Proceedings of the 26th International Symposium on Controlled Release of Bioactive Materials and the Second Conference on Consumer and Diversified Products
accessLevelPublic
1999 43 12
Poly(ortho esters)Encyclopedia of controlled drug delivery
accessLevelRestricted
1999 112 0
Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell UptakePharmaceutical research
accessLevelPublic
1999 45 104
Biodegradable implantsAsian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 395 50
Evaluation of poly(ortho ester) for intraocular application in rabbits: biocompatibility assessment and in vitro degradationCRS proceedings
accessLevelPublic
1999 63 101
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complexEuropean journal of pharmaceutical sciences
accessLevelRestricted
1999 514 0
Poly(ortho ester): a new biocompatible intraocular drug delivery systemAsian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 83 16
Ocular tolerance of preservatives on the murine corneaEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 417 1
Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactateJournal of biomaterials science. Polymer ed
accessLevelRestricted
1999 139 0
Stability studies of a somatostatin analogue in biodegradable implantsInternational journal of pharmaceutics
accessLevelRestricted
1999 442 1
Mucosal drug delivery, ocularEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 144 0
Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implantsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 548 3
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localizationEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1999 458 2
Mucosal drug delivery, intravitrealEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 153 0
Gamma scintigraphy as tool for the evaluation of precorneal residence time: influence of the methodologyCRS proceedings
accessLevelPublic
1999 47 39
NanoparticlesEncyclopedia of controlled drug delivery
accessLevelRestricted
1999 200 0
Protein delivery from extruded poly(ortho esters)Asian Conference and Exhibition of Controlled Release
accessLevelPublic
1999 395 45
Application of fluorescence correlation spectroscopy for the characterisation of drug delivery systemsCRS proceedings
accessLevelPublic
1999 49 70
Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester)International journal of pharmaceutics
accessLevelRestricted
1999 584 0
Synthesis and characterization of self-catalyzed poly(ortho ester)Biomaterials
accessLevelRestricted
1998 626 0
Topical use of chitosan in ophthalmology : tolerance assessment by confocal microscopy and precorneal retention evaluation by gamma scintigraphy2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 517 2
Synthesis and characterization of new bioerodible polymers designed for controlled drug release applications2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 309 1
pH-Sensitive microparticles as oral delivery systems for antiinfective agents of poor water solubility2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 522 1
In vitro drug release from self-catalyzed poly(ortho ester): Case study of 5-fluorouracilJournal of controlled release
accessLevelRestricted
1998 193 0
Injection-moulding versus extrusion for the preparation of long-acting biodegradable implants2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 623 1
Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental cariesEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1998 482 1
Biodegradable polymers for the controlled release of ocular drugsProgress in polymer science
accessLevelRestricted
1998 57 0
Chitosan: a unique polysaccharide for drug deliveryDrug development and industrial pharmacy
accessLevelRestricted
1998 558 0
A biodegradable polymer designed for concomitant delivery of dexamethasone and 5-fluorouracil to the eye2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 465 1
Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infectionsJournal of controlled release
accessLevelRestricted
1998 653 0
Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) containing gentamicin for the treatment of external ophthalmic infections2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 433 1
Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogueJournal of controlled release
accessLevelRestricted
1998 212 0
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimeticsAdvanced drug delivery reviews
accessLevelRestricted
1998 451 0
Poly (D,L-lactic acid) nanoparticles as phosphorothioate oligonucleotide carriers in U937 cells2nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
accessLevelRestricted
1998 446 1
Evaluation of Soluble Bioadhesive Ophthalmic Drug Inserts (BODI®) for Prolonged Release of Gentamicin: Lachrymal Pharmacokinetics and Ocular ToleranceJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1998 133 0
Bioerodible Polymers for Ocular Drug DeliveryCritical reviews in therapeutic drug carrier systems
accessLevelRestricted
1998 151 0
Influence of irradiation sterilization on a semi-solid poly(ortho ester)International journal of pharmaceutics
accessLevelRestricted
1998 553 0
Therapeutic applications of retinoids in ophthalmologyInternational journal of pharmaceutics
accessLevelRestricted
1997 436 2
Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug releaseInternational journal of pharmaceutics
accessLevelRestricted
1997 511 1
Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogueEuropean journal of pharmaceutical sciences
accessLevelRestricted
1997 480 0
Prophylaxis of caries : in vivo evaluation of various oral fluoride containing preparations designed to optimize salivary concentrationsProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelRestricted
1997 66 0
Influence of Irradiation Sterilization on Polymers Used as Drug Carriers : A ReviewDrug development and industrial pharmacy
accessLevelRestricted
1997 558 1
Determination of dexamethasone in tears by capillary electrophoresisJournal of chromatography. B, Biomedical sciences and applications
1997 515 0
Confocal Microscopy as a Tool for the Investigation of the Anterior Part of the EyeJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1997 121 0
Ocular drug delivery in veterinary medicineAdvanced drug delivery reviews
accessLevelRestricted
1997 535 0
PLA-PEG nanoparticles: preparation and cell interaction studiesProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 42 24
In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral useEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1997 446 1
Synthesis and characterization of ointment-like self-catalyzed poly(ortho ester)Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 50 149
New generation of poly(ortho esters): synthesis, characterization, kinetics, sterilization and biocompatibilityJournal of controlled release
accessLevelRestricted
1997 272 0
Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axisEuropean journal of pharmaceutics and biopharmaceutics
accessLevelRestricted
1997 200 0
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulationsPharmaceutica Acta Helvetiae
accessLevelRestricted
1997 49 0
Combined release of dexamethasone and gentamicin from an ocular insert for treatment of external ophthalmic infectionsProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 81 88
Development of a long-term delivery system for RC-160, a somatostatin analogProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 46 30
Uptake of oligonucleotide loaded nanoparticles in prostatic cancer cells and their intracellular localizationProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 101 78
Improved biocompatibility of a viscous bioerodable poly(orthoester) by controlling the environmental pHProceedings of the 24th International Symposium on Controlled Release of Bioactive Materials
accessLevelPublic
1997 41 98
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvementJournal of biomedical materials research
accessLevelRestricted
1997 120 0
Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticlesActa pharmaceutica
accessLevelPublic
1996 387 105
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogsPharmaceutical research
accessLevelPublic
1996 45 35
Basis for Dosing Time-Dependent Changes in the Ocular and Systemic Absorption of Topically Applied TimololJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1996 130 0
Development of a Novel Soluble Ophthalmic Insert: Evaluation of Ocular Tolerance in RabbitsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 188 55
Gamma Scintigraphic Comparison of Eyedrops Containing Pilocarpine in Healthy VolunteersJournal of Ocular Pharmacology and Therapeutics
accessLevelRestricted
1996 111 0
Biomaterials in Ophthalmic Drug DeliveryEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 519 90
The Use of Drug-Loaded Nanoparticles in Cancer ChemotherapyMicroencapsulation : methods and industrial applications
accessLevelRestricted
1996 48 0
Mucoadhesive Semi-Solid Formulations for Intraoral Use Containing SucralfateEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1996 303 163
Biodegradable nanoparticles — From sustained release formulations to improved site specific drug deliveryJournal of controlled release
accessLevelRestricted
1996 89 0
Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systemsBiomaterials
accessLevelRestricted
1996 508 2
Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insertPharmaceutical research
accessLevelPublic
1995 50 218
Patent Literature Review of Ophthalmic InsertsDrug development and industrial pharmacy
accessLevelRestricted
1995 531 2
The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester)Journal of controlled release
accessLevelRestricted
1995 82 0
Use of Insoluble Biodegradable Polymers in Ophthalmic Systems for the Sustained Release of DrugsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1995 306 196
Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigationJournal of controlled release
accessLevelRestricted
1995 47 0
Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogelsAdvanced drug delivery reviews
accessLevelRestricted
1995 644 0
New Approach for the Preparation of Nanoparticles by an Emulsification-Diffusion MethodEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1995 655 1,349
PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary TumoursJournal of Pharmacy and Pharmacology
accessLevelRestricted
1995 148 0
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife sciences
accessLevelRestricted
1995 150 1
Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to MiceJournal of Pharmaceutical Sciences
accessLevelRestricted
1995 115 0
Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery: validation and radiation effectsPharmaceutical research
accessLevelPublic
1994 112 129
In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymersJournal of biomaterials science. Polymer ed
accessLevelRestricted
1994 181 0
Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracilJournal of biomedical materials research
accessLevelRestricted
1994 156 0
Application of Medical Imaging to Pharmaceutical Research: the Example of Gamma Scintigraphy. I: Technological AspectsEuropean journal of pharmaceutics and biopharmaceutics
accessLevelPublic
1994 194 19
Long-term histopathological study of new polypeptidic biomaterialsBiomaterials
accessLevelRestricted
1992 534 2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle sizeInternational journal of pharmaceutics
accessLevelRestricted
1992 675 2
Aqueous nanodispersions prepared by a salting-out processInternational journal of pharmaceutics
accessLevelRestricted
1992 617 1
Du fard des Egyptiens aux pseudo-latex : évolution des formes médicamenteuses en ophtalmologieCahiers de la Faculté des sciences / Université de Genève
accessLevelPublic
1982 4 7
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack